67
https://pubmed.ncbi.nlm.nih.gov/38117686
The abstract discusses the findings of a review on gene therapy for Leber hereditary optic neuropathy (LHON), highlighting the observed bilateral visual improvement with unilateral treatment and the potential of future gene therapy strategies to achieve optimal visual outcomes by reducing disease penetrance and mitigating retinal ganglion cell loss.